JAZZ Jazz Pharmaceuticals plc - Ordinary Shares
$254,94
Cena · Sie 19, 2026
Dane fundamentalne na dzień Sie 3, 2026
Zakres 52 tyg.
$118–$265
93% of range
Ocena Analityków
BUY
26 analysts
Cena Docelowa
$281
+10% upside
P/E (TTM)
-29.1
ROE
—
Marża Zysku Netto
—
O Jazz Pharmaceuticals plc - Ordinary Shares Przegląd firmy z Wikipedii
Jazz Pharmaceuticals plc is an American global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.
Czytaj więcej
Jazz Pharmaceuticals plc (a merger of Jazz Pharmaceuticals, Inc. and Azur Pharma plc) is an American global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.
One of the company's considerable products is the United States Food and Drug Administration (FDA) approved drug Xyrem (sodium oxybate), the sodium salt of the naturally occurring neurotransmitter γ-Hydroxybutyric acid (GHB). In 2017, net product sales of Xyrem were $1.187 billion, which represented 74% of the company's total net product sales. In 2019, Jazz was granted FDA-approval to market Sunosi with indications for treating excessive daytime sleepiness (EDS) in narcolepsy as well as obstructive sleep apnea (OSA). In 2022, it was announced that Axsome Therapeutics would be acquiring Sunosi from Jazz Pharmaceuticals.
In 2007, the company pled guilty to felony charges related to its illegal marketing of Xyrem for off-label use.
The company is also a member of the Pharmaceutical Research and Manufacturers of America (PhRMA).
Company history and acquisitions
2010–2019
On 18 February 2010, the FDA accepted a new drug application for JZP-6 (Sodium oxybate) for the treatment of Fibromyalgia. In the following December, a new patent was issued for Sodium Oxybate.
On September 19, 2011, Jazz Pharmaceuticals merged with Irish Azur Pharma plc to form Jazz Pharmaceuticals plc. The Azur Pharma seat in Dublin became the headquarters of the combined company. Azur Pharma had been marketing specialty pharmaceutical products in the central nervous system (CNS) and women's health areas with US operations in Philadelphia.
On 26 April 2012, the company acquired EUSA Pharma for $650 million (plus $50 million in milestone payments). In September, the company sold its Women's Health business to Meda for $95 million. In December, the company began clinical trial of intravenous Erwinaze in patients with Acute Lymphoblastic Leukemia.
In January 2014, the company announced it would acquire the rare disease drug developer Gentium SpA and its lead product Defitelio for $1 billion.
In May 2016, the company announced it would acquire Alizé Pharma II for $20.5 million. At the end of the same month, the company announced its then largest acquisition, with the purchase of Celator Pharmaceuticals for $1.5 billion. As a result, Jazz obtained the rights to breakthrough therapy Vyxeos (liposomal daunorubicin and cytarabine) for treatment of acute myeloid leukemia.
In August 2019, the company announced it would acquire Cavion Inc. for up to $310 million.
2020–present
In January 2021, Jazz announced it would acquire cannabis-focused medicinal drug company GW Pharmaceuticals for US$7.2 billion. This acquisition added the medication Epidiolex (cannabidiol), developed to treat severe epilepsy syndromes, to the company's portfolio.
In November 2025, Jazz Pharmaceuticals announced positive results from its Phase 3 trial for its cancer drug, Ziihera, a potential treatment for advanced gastroesophageal cancer.
Acquisition history
The following is an illustration of the company's mergers, acquisitions, spin-offs and historical predecessors:
== References ==
Źródło: Wikipedia (Angielski), CC BY-SA 4.0 · Zobacz w Wikipedii ↗
JAZZ Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$254.94
Kapitalizacja Rynkowa
—
P/E (TTM)
-29.1
EPS (TTM)
$-5.84
Przychody (TTM)
$4.27B
Stopa dywidendy
—
ROE
—
D/E Dług/Kapitał
—
Zakres 52 tyg.
$118 – $265
JAZZ Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Configure
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody i Zysk Netto
$4.27B
2016-12-31
→
2025-12-31
EPS
$-5.84
2016-12-31
→
2025-12-31
Wolny przepływ pieniężny
—
Marże
—
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Wskaźnik
Trend 5-letni
JAZZ
Mediana porównawcza
P/E (TTM)
-29.1
530.6
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Wskaźnik
Trend 5-letni
JAZZ
Mediana porównawcza
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Wskaźnik
Trend 5-letni
JAZZ
Mediana porównawcza
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Wskaźnik
Trend 5-letni
JAZZ
Mediana porównawcza
Revenue YoY (Przychody R/R)
4.9%
—
Revenue CAGR 3Y (Przychody CAGR 3L)
5.3%
—
Revenue CAGR 5Y (Przychody CAGR 5L)
12.5%
—
EPS YoY
41.8%
—
Net Income YoY (Zysk Netto R/R)
35.0%
—
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
Wskaźnik
Trend 5-letni
JAZZ
Mediana porównawcza
JAZZ Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
KUP
26 analityków
- Mocne kupno 7 26,9%
- Kup 17 65,4%
- Trzymaj 2 7,7%
- Sprzedaj 0 0,0%
- Mocna sprzedaż 0 0,0%
12-miesięczny cel cenowy
20 analityków · 2026-08-15
Mediana
$285.00
Teraz
$254.94
Niski
$196.00
Wysoki
$315.00
Średni cel
$285.00
+11,8%
Średnia cel
$281.10
+10,3%
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
-0.06%
| Okres | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|
| 30 czerwca 2026 | $5.71 | $6.30 | -0.59% |
| 31 marca 2026 | $6.34 | $4.66 | 1.7% |
| 31 grudnia 2025 | $6.64 | $6.65 | -0.01% |
| 30 września 2025 | $8.13 | $6.04 | 2.1% |
| 30 czerwca 2025 | $-8.25 | $-7.76 | -0.49% |
| 31 marca 2025 | $1.68 | $4.75 | -3.1% |
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| JAZZ | — | -29.1 | 4.9% | — | — | — |
| GHRS | — | — | — | — | — | — |
| PRGO | $1.92B | -1.4 | -2.8% | -33.5% | -38.5% | 35.1% |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 14
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.27B | $4.07B | $3.83B | $3.66B | $3.09B | $2.36B | $2.16B | $1.89B | $1.62B | $1.49B | $1.32B | $1.17B | |
| R&D Expense | · | · | · | · | · | · | $300M | $227M | $198M | $162M | $135M | $85M | |
| SG&A Expense | $1.81B | $1.39B | $1.34B | $1.42B | $1.45B | $854M | $737M | $684M | $544M | $503M | $449M | $406M | |
| Operating Expenses | $4.70B | $3.35B | $3.26B | $3.72B | $2.92B | $1.99B | $1.63B | $1.28B | $1.09B | $896M | $817M | $977M | |
| Operating Income | $-430M | $717M | $579M | $-66M | $170M | $378M | $532M | $615M | $529M | $592M | $508M | $196M | |
| Interest Income | $86M | $106M | $65M | $12M | $2M | $11M | $20M | $17M | $4M | · | · | · | |
| Other Non-op | · | · | · | · | · | · | · | · | · | · | $1M | $9M | |
| Pretax Income | $-628M | $470M | $298M | $-373M | $-113M | $275M | $454M | $529M | $441M | $532M | $436M | $152M | |
| Income Tax | $-272M | $-91M | $-120M | $-159M | $216M | $34M | $-73M | $80M | $-48M | $135M | $106M | $94M | |
| Net Income | $-356M | $560M | $415M | $-224M | $-330M | $239M | $523M | $447M | $488M | $397M | $330M | $58M | |
| EPS (Basic) | $-5.84 | $9.06 | $6.55 | $-3.58 | $-5.52 | $4.28 | $9.22 | $7.45 | $8.13 | $6.56 | $5.38 | $0.98 | |
| EPS (Diluted) | $-5.84 | $8.65 | $6.10 | $-3.58 | $-5.52 | $4.22 | $9.09 | $7.30 | $7.96 | $6.41 | $5.23 | $0.93 | |
| Shares (Basic) | 60,981,000 | 61,838,000 | 63,291,000 | 62,539,000 | 59,694,000 | 55,712,000 | 56,749,000 | 59,976,000 | 60,018,000 | 60,500,000 | 61,232,000 | 59,746,000 | |
| Shares (Diluted) | 60,981,000 | 66,007,000 | 72,066,000 | 62,539,000 | 59,694,000 | 56,517,000 | 57,550,000 | 61,221,000 | 61,317,000 | 61,870,000 | 63,036,000 | 62,614,000 |
Bilans 26
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.39B | $2.41B | $1.51B | $881M | $591M | $1.06B | $637M | $310M | $386M | $366M | $989M | $684M | |
| Receivables | $831M | $717M | $706M | $651M | $563M | $396M | $356M | $264M | $224M | $234M | $210M | $186M | |
| Inventory | $417M | $480M | $597M | $714M | $1.07B | $95M | $79M | $53M | $43M | $34M | $19M | $30M | |
| Prepaid Expense | $152M | $177M | $185M | $92M | $131M | $62M | $39M | $25M | $23M | $25M | $21M | $13M | |
| Other Current Assets | $324M | $262M | $321M | $267M | $252M | $152M | $79M | $68M | $77M | $29M | $19M | $21M | |
| Current Assets | $4.17B | $4.63B | $3.44B | $2.61B | $2.61B | $2.84B | $1.63B | $1.23B | $968M | $748M | $1.26B | $1.02B | |
| PP&E (Net) | · | · | · | · | · | $128M | $132M | $200M | $170M | $107M | $86M | $58M | |
| PP&E (Gross) | · | · | · | · | · | $196M | $187M | $250M | $211M | $140M | $109M | $74M | |
| Accum. Depreciation | · | · | · | · | · | $68M | $55M | $50M | $41M | $32M | $24M | $15M | |
| Goodwill | $1.83B | $1.72B | $1.75B | $1.69B | $1.83B | $958M | $920M | $928M | $948M | $894M | $657M | $703M | |
| Intangibles | $4.43B | $4.76B | $5.42B | $5.79B | $7.15B | $2.20B | $2.44B | $2.73B | $2.98B | $3.01B | $1.19B | $1.44B | |
| Other Non-current Assets | $99M | $114M | $67M | $55M | $41M | $26M | $48M | $43M | $16M | $14M | $9M | $16M | |
| Total Assets | $11.66B | $12.01B | $11.39B | $10.84B | $12.30B | $6.54B | $5.54B | $5.20B | $5.12B | $4.80B | $3.33B | $3.34B | |
| Accounts Payable | $122M | $78M | $103M | $91M | $100M | $27M | $46M | $41M | $24M | $22M | $22M | $25M | |
| Accrued Liabilities | $1.03B | $911M | $794M | $803M | $666M | $353M | $270M | $265M | $199M | $193M | $164M | $164M | |
| Current Liabilities | $2.24B | $1.04B | $1.54B | $933M | $809M | $654M | $364M | $345M | $294M | $257M | $227M | $217M | |
| Capital Leases | $51M | $39M | $59M | $72M | $87M | $140M | $151M | $0 | · | · | · | · | |
| Deferred Tax | $594M | $677M | $848M | $944M | $1.30B | $130M | $224M | $309M | $383M | $557M | $283M | $375M | |
| Other Non-current Liabilities | $124M | $87M | $105M | $107M | $117M | $101M | $109M | $219M | $177M | $113M | $69M | $38M | |
| Long-term Debt | $5.36B | $6.11B | $5.71B | $5.72B | $6.05B | $2.09B | $1.61B | $1.60B | $1.58B | $2.03B | $1.19B | $1.34B | |
| Common Stock | $0 | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | |
| Retained Earnings | $646M | $1.13B | $879M | $734M | $830M | $1.16B | $1.07B | $841M | $918M | $529M | $303M | $35M | |
| AOCI | $-569M | $-948M | $-842M | $-1.13B | $-400M | $-134M | $-223M | $-198M | $-141M | $-317M | $-267M | $-122M | |
| Stockholders' Equity | $4.32B | $4.09B | $3.74B | $3.09B | $3.97B | $3.66B | $3.11B | $2.76B | $2.71B | $1.88B | $1.71B | $1.37B | |
| Liabilities + Equity | $11.66B | $12.01B | $11.39B | $10.84B | $12.30B | $6.54B | $5.54B | $5.20B | $5.12B | $4.80B | $3.33B | $3.34B | |
| Shares Outstanding | 61,400,000 | 60,600,000 | 62,255,000 | 63,214,000 | 61,633,000 | 56,171,000 | 56,140,000 | 57,704,000 | 58,898,000 | 59,820,000 | 61,305,000 | 60,643,000 |
Przepływy pieniężne 12
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $42M | $33M | $30M | $30M | $27M | $19M | $15M | $15M | $13M | $12M | $10M | · | |
| Stock-based Comp | $291M | $248M | $227M | $222M | $189M | $121M | $111M | $102M | $107M | $99M | $92M | $70M | |
| Deferred Tax | $-445M | $-208M | $-260M | $-292M | $69M | $-137M | $-237M | $-89M | $-226M | $-41M | $-68M | $-49M | |
| Amort. of Intangibles | $655M | $627M | $608M | $599M | $526M | $260M | $355M | $201M | $152M | $102M | $98M | $127M | |
| Restructuring | · | · | · | · | · | · | · | · | · | · | $2M | $2M | |
| Operating Cash Flow | $1.36B | $1.40B | $1.09B | $1.27B | $779M | $900M | $776M | $799M | $693M | $592M | $532M | $408M | |
| CapEx | $59M | $38M | $24M | $29M | $28M | $15M | $40M | $20M | $29M | $10M | $36M | $36M | |
| Investing Cash Flow | $-1.51B | $-508M | $-163M | $-446M | $-5.21B | $-1.01B | $-155M | $-394M | $-269M | $-1.75B | $-2M | $-1.07B | |
| Stock Repurchased | $125M | $311M | $270M | $54.0K | $0 | $147M | $301M | $524M | $99M | $278M | $62M | $42M | |
| Financing Cash Flow | $-873M | $21M | $-305M | $-529M | $3.97B | $528M | $-294M | $-479M | $-409M | $541M | $-214M | $711M | |
| Net Change in Cash | $-1.02B | $907M | $625M | $290M | $-466M | $420M | $328M | $-76M | $20M | $-623M | $305M | $48M | |
| Taxes Paid | $122M | $115M | $178M | · | · | · | · | · | · | · | · | · |
Stopy Wzrostu 7
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 4.9% | 6.1% | 4.8% | 18.3% | 30.9% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 5.3% | 9.6% | 17.5% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 12.5% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | · | 41.8% | · | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | · | · | 13.1% | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | · | 35.0% | · | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | · | · | 20.2% | · | · | · | · | · | · | · | · | · |
Wycena (TTM) 5
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4.27B | $4.07B | $3.83B | $3.66B | $3.09B | $2.36B | $2.16B | $1.89B | $1.62B | $1.49B | $1.32B | $1.17B | |
| Net Income TTM | $-356M | $560M | $415M | $-224M | $-330M | $239M | $523M | $447M | $488M | $397M | $330M | $58M | |
| P/E | -29.1 | 14.2 | 20.2 | -44.5 | -23.1 | 39.1 | 16.4 | 17.0 | 16.9 | 17.0 | 26.9 | 176.1 | |
| P / Tangible Book | · | · | · | · | · | 18.3 | · | · | · | · | · | · | |
| Earnings Yield | -3.4% | 7.0% | 5.0% | -2.2% | -4.3% | 2.6% | 6.1% | 5.9% | 5.9% | 5.9% | 3.7% | 0.57% |
Rachunek zysków i strat 13
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.21B | $1.07B | $1.20B | $1.13B | $1.05B | $898M | $1.09B | $1.05B | $1.02B | $902M | $1.01B | $972M | $957M | $893M | $972M | $941M | |
| SG&A Expense | $389M | $353M | $406M | $531M | $358M | $514M | $369M | $326M | $339M | $352M | $396M | $308M | $341M | $298M | $383M | $358M | |
| Operating Expenses | $960M | $732M | $943M | $1.07B | $1.73B | $954M | $897M | $795M | $824M | $836M | $889M | $800M | $800M | $767M | $1.24B | $916M | |
| Operating Income | $248M | $337M | $255M | $58M | $-686M | $-56M | $191M | $260M | $199M | $66M | $122M | $172M | $158M | $126M | $-263M | $25M | |
| Interest Income | $25M | $23M | $20M | $19M | $19M | $28M | $32M | $26M | $25M | $23M | $21M | $19M | $15M | $11M | $7M | $4M | |
| Pretax Income | $211M | $299M | $208M | $9M | $-736M | $-110M | $133M | $201M | $138M | $-2M | $62M | $100M | $82M | $55M | $-340M | $-60M | |
| Income Tax | $18M | $6M | $5M | $-242M | $-17M | $-18M | $-58M | $-15M | $-31M | $12M | $-33M | $-47M | $-24M | $-15M | $-100M | $-43M | |
| Net Income | $193M | $293M | $203M | $251M | $-718M | $-92M | $191M | $215M | $169M | $-15M | $94M | $147M | $104M | $69M | $-241M | $-20M | |
| EPS (Basic) | $3.05 | $4.73 | $3.28 | $4.14 | $-11.74 | $-1.52 | $3.11 | $3.50 | $2.68 | $-0.23 | $1.50 | $2.33 | $1.63 | $1.09 | $-3.86 | $-0.31 | |
| EPS (Diluted) | $2.78 | $4.43 | $3.34 | $4.08 | $-11.74 | $-1.52 | $2.97 | $3.42 | $2.49 | $-0.23 | $1.40 | $2.14 | $1.52 | $1.04 | $-3.85 | $-0.31 | |
| Shares (Basic) | 63,200,000 | 61,900,000 | -121,888,000 | 60,696,000 | 61,200,000 | 61,000,000 | -124,995,000 | 61,414,000 | 62,882,000 | 62,537,000 | -127,308,000 | 63,114,000 | 63,991,000 | 63,494,000 | -124,547,000 | 62,785,000 | |
| Shares (Diluted) | 69,400,000 | 66,100,000 | -122,798,000 | 61,606,000 | 61,200,000 | 61,000,000 | -129,329,000 | 63,174,000 | 69,625,000 | 62,537,000 | -146,538,000 | 71,293,000 | 73,540,000 | 73,771,000 | -126,584,000 | 62,785,000 | |
| EBITDA | $248M | $337M | · | $58M | $-686M | $-56M | · | $260M | $199M | $66M | · | $172M | $158M | $126M | · | $25M |
Bilans 24
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.62B | $1.84B | $1.39B | $1.33B | $1.19B | $1.86B | $2.41B | $2.22B | $1.36B | $1.44B | · | $1.34B | $1.28B | $1.17B | · | $839M | |
| Receivables | $881M | $836M | $831M | $764M | $714M | $653M | $717M | $724M | $698M | $707M | · | $628M | $610M | $624M | · | $601M | |
| Inventory | $443M | $438M | $417M | $483M | $505M | $493M | $480M | $539M | $543M | $577M | · | $612M | $657M | $675M | · | $728M | |
| Prepaid Expense | $200M | $150M | $152M | $147M | $164M | $150M | $177M | $155M | $134M | $123M | · | $110M | $107M | $73M | · | $93M | |
| Other Current Assets | $244M | $285M | $324M | $315M | $298M | $260M | $262M | $354M | $326M | $315M | · | $310M | $272M | $245M | · | $250M | |
| Current Assets | $3.97B | $4.58B | $4.17B | $3.76B | $3.35B | $4.13B | $4.63B | $4.39B | $3.68B | $3.54B | · | $3.25B | $3.01B | $2.78B | · | $2.57B | |
| Goodwill | $1.80B | $1.80B | $1.83B | $1.83B | $1.84B | $1.76B | $1.72B | $1.80B | $1.74B | $1.74B | · | $1.71B | $1.74B | $1.72B | · | $1.59B | |
| Intangibles | $4.03B | $4.20B | $4.43B | $4.57B | $4.77B | $4.72B | $4.76B | $5.14B | $5.08B | $5.24B | · | $5.42B | $5.71B | $5.76B | · | $5.57B | |
| Other Non-current Assets | $86M | $95M | $99M | $103M | $121M | $117M | $114M | $75M | $71M | $71M | · | $76M | $66M | $64M | · | $35M | |
| Total Assets | $11.08B | $11.86B | $11.66B | $11.36B | $10.94B | $11.53B | $12.01B | $12.26B | $11.36B | $11.33B | · | $11.20B | $11.26B | $11.05B | · | $10.38B | |
| Accounts Payable | $128M | $100M | $122M | $152M | $89M | $96M | $78M | $85M | $97M | $81M | · | $110M | $98M | $125M | · | $102M | |
| Accrued Liabilities | $1.03B | $1.02B | $1.03B | $1.00B | $875M | $1.06B | $911M | $859M | $801M | $827M | · | $770M | $748M | $712M | · | $668M | |
| Current Liabilities | $2.23B | $2.25B | $2.24B | $2.27B | $2.07B | $1.22B | $1.04B | $1.03B | $1.56B | $1.56B | · | $1.57B | $945M | $909M | · | $813M | |
| Capital Leases | $44M | $47M | $51M | $53M | $55M | $39M | $39M | $71M | $68M | $56M | · | $62M | $66M | $72M | · | $73M | |
| Deferred Tax | $529M | $548M | $594M | $629M | $682M | $671M | $677M | $792M | $775M | $810M | · | $841M | $911M | $932M | · | $934M | |
| Other Non-current Liabilities | $141M | $162M | $125M | $109M | $94M | $91M | $87M | $111M | $99M | $97M | · | $127M | $127M | $109M | · | $124M | |
| Long-term Debt | $4.35B | $5.35B | $5.36B | $5.36B | $5.36B | $5.37B | $6.11B | $6.11B | $5.71B | $5.71B | · | $5.72B | $5.72B | $5.72B | · | $5.73B | |
| Total Debt | $4.35B | $5.35B | · | $5.36B | $5.36B | $5.37B | · | $6.11B | $5.71B | $5.71B | · | $5.72B | $5.72B | $5.72B | · | $5.73B | |
| Common Stock | $0 | $0 | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | · | $6.0K | $6.0K | $6.0K | · | $6.0K | |
| Retained Earnings | $1.13B | $939M | $646M | $443M | $191M | $1.03B | $1.13B | $936M | $871M | $864M | · | $884M | $812M | $803M | · | $974M | |
| AOCI | $-662M | $-651M | $-569M | $-570M | $-486M | $-786M | $-948M | $-603M | $-888M | $-882M | · | $-1.04B | $-867M | $-980M | · | $-1.62B | |
| Stockholders' Equity | $4.80B | $4.53B | $4.32B | $3.96B | $3.71B | $4.17B | $4.09B | $4.17B | $3.76B | $3.70B | $3.74B | $3.49B | $3.53B | $3.34B | $3.09B | $2.75B | |
| Liabilities + Equity | $11.08B | $11.86B | $11.66B | $11.36B | $10.94B | $11.53B | $12.01B | $12.26B | $11.36B | $11.33B | · | $11.20B | $11.26B | $11.05B | · | $10.38B | |
| Shares Outstanding | 64,800,000 | 62,700,000 | 61,435,000 | 60,740,000 | 60,640,000 | 61,623,000 | 60,631,000 | 60,443,000 | 61,745,000 | 63,028,000 | 62,255,000 | 62,945,000 | · | · | 63,214,000 | · |
Przepływy pieniężne 10
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $73M | $74M | $71M | $88M | $65M | $68M | $70M | $60M | $57M | $61M | $53M | $56M | $61M | $56M | $62M | $57M | |
| Deferred Tax | $-39M | $-66M | $-63M | $-271M | $-66M | $-44M | $-2M | $-64M | $-75M | $-66M | $-36M | $-79M | $-79M | $-66M | $-145M | $-65M | |
| Amort. of Intangibles | $170M | $172M | $170M | $168M | $162M | $154M | $159M | $157M | $155M | $156M | $152M | $155M | $152M | $150M | $137M | $141M | |
| Operating Cash Flow | $416M | $408M | $363M | $475M | $89M | $430M | $399M | $399M | $331M | $267M | $167M | $307M | $297M | $321M | $342M | $418M | |
| CapEx | $18M | $20M | $17M | $15M | $13M | $14M | $13M | $11M | $7M | $7M | $10M | $4M | $6M | $4M | $9M | $-5M | |
| Investing Cash Flow | $355M | $123M | $-372M | $-328M | $-641M | $-169M | $-193M | $214M | $-257M | $-272M | $102M | $-174M | $-86M | $-5M | $-324M | $5M | |
| Stock Repurchased | · | · | $0 | $0 | · | · | $0 | $150M | · | · | $100M | $74M | · | · | $0 | $0 | |
| Financing Cash Flow | $-994M | $-78M | $75M | $-11M | $-125M | $-814M | $-8M | $246M | $-161M | $-57M | $-100M | $-78M | $-97M | $-30M | $20M | $-289M | |
| Net Change in Cash | $-224M | $452M | $66M | $136M | $-672M | $-551M | $195M | $862M | $-88M | $-63M | $171M | $53M | $114M | $286M | $42M | $128M | |
| Free Cash Flow | · | $388M | · | · | · | $416M | · | · | · | $260M | · | · | · | $317M | · | · |
Rentowność 7
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 20.5% | 31.5% | · | 5.1% | -65.6% | -6.2% | · | 24.7% | 19.5% | 7.3% | · | 17.7% | 16.5% | 14.1% | · | 2.6% | |
| Net Margin | 16.0% | 27.4% | · | 22.3% | -68.7% | -10.3% | · | 20.4% | 16.5% | -1.6% | · | 15.1% | 10.9% | 7.8% | · | -2.1% | |
| Pretax Margin | 17.5% | 28.0% | · | 0.80% | -70.3% | -12.2% | · | 19.0% | 13.5% | -0.18% | · | 10.2% | 8.5% | 6.2% | · | -6.4% | |
| EBITDA Margin | 20.5% | 31.5% | · | 5.1% | -65.6% | -6.2% | · | 24.7% | 19.5% | 7.3% | · | 17.7% | 16.5% | 14.1% | · | 2.6% | |
| ROA | 1.8% | 2.5% | · | 2.1% | -6.4% | -0.81% | · | 1.8% | 1.5% | -0.13% | · | 1.4% | 0.93% | 0.61% | · | -0.17% | |
| ROE | 4.5% | 6.7% | · | 6.2% | -19.2% | -2.4% | · | 5.6% | 4.6% | -0.42% | · | 4.7% | 3.1% | 2.0% | · | -0.59% | |
| ROIC | 2.5% | 3.3% | · | 17.2% | -7.4% | -0.49% | · | 2.7% | 2.6% | 5.8% | · | 2.8% | 2.2% | 1.8% | · | 0.08% |
Płynność i wypłacalność 4
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.8 | 2.0 | · | 1.7 | 1.6 | 3.4 | · | 4.3 | 2.4 | 2.3 | · | 2.1 | 3.2 | 3.1 | · | 3.2 | |
| Quick Ratio | 1.1 | 1.2 | · | 0.9 | 0.9 | 2.1 | · | 2.9 | 1.3 | 1.4 | · | 1.2 | 2.0 | 2.0 | · | 1.8 | |
| Debt / Equity | 0.9 | 1.2 | · | 1.4 | 1.4 | 1.3 | · | 1.5 | 1.5 | 1.5 | · | 1.6 | 1.6 | 1.7 | · | 2.1 | |
| LT Debt / Equity | 0.7 | 1.0 | · | 1.1 | 1.2 | 1.3 | · | 1.5 | 1.4 | 1.4 | · | 1.5 | 1.6 | 1.7 | · | 2.1 |
Efektywność 2
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Receivables Turnover | 1.5 | 1.4 | · | 1.5 | 1.5 | 1.3 | · | 1.6 | 1.6 | 1.4 | · | 1.6 | 1.6 | 1.5 | · | 1.7 |
Wycena (TTM) 13
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4.45B | $4.14B | · | $4.12B | $4.02B | $3.88B | · | $3.95B | $3.86B | $3.72B | · | $3.76B | $3.72B | $3.58B | · | $3.53B | |
| Net Income TTM | $19M | $-266M | · | $-345M | $-427M | $276M | · | $516M | $405M | $306M | · | $301M | $189M | $86M | · | $-36M | |
| Market Cap | $15.61B | $11.85B | · | $8.01B | $6.44B | $7.65B | · | $6.73B | $6.59B | $7.59B | · | $8.15B | · | · | · | · | |
| Enterprise Value | $18.35B | $15.36B | · | $12.04B | $10.61B | $11.16B | · | $10.63B | $10.94B | $11.86B | · | $12.53B | · | · | · | · | |
| P/E | -535.5 | -39.8 | · | -22.9 | -14.4 | 29.8 | · | 14.2 | 18.0 | 26.9 | · | 29.5 | 44.3 | 111.7 | · | -225.9 | |
| P/S | 3.5 | 2.9 | · | 1.9 | 1.6 | 2.0 | · | 1.7 | 1.7 | 2.0 | · | 2.2 | · | · | · | · | |
| P/B | 3.3 | 2.6 | · | 2.0 | 1.7 | 1.8 | · | 1.6 | 1.8 | 2.1 | · | 2.3 | · | · | · | · | |
| P / Cash Flow | · | 29.0 | · | · | · | 17.8 | · | · | · | 28.4 | · | · | · | · | · | · | |
| P / FCF | · | 30.5 | · | · | · | 18.4 | · | · | · | 29.2 | · | · | · | · | · | · | |
| EV / EBITDA | 73.9 | 45.6 | · | 209.4 | -15.5 | -199.6 | · | 40.8 | 54.9 | 179.1 | · | 72.7 | · | · | · | · | |
| EV / FCF | · | 39.5 | · | · | · | 26.8 | · | · | · | 45.5 | · | · | · | · | · | · | |
| EV / Revenue | 4.1 | 3.7 | · | 2.9 | 2.6 | 2.9 | · | 2.7 | 2.8 | 3.2 | · | 3.3 | · | · | · | · | |
| Earnings Yield | -0.19% | -2.5% | · | -4.4% | -6.9% | 3.4% | · | 7.0% | 5.5% | 3.7% | · | 3.4% | 2.3% | 0.90% | · | -0.44% |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Przychody | $4.27B | $4.07B | $3.83B | $3.66B | $3.09B |
| Zysk netto | $-356M | $560M | $415M | $-224M | $-330M |
| Rozwodniony EPS | $-5.84 | $8.65 | $6.10 | $-3.58 | $-5.52 |
Najnowsze wiadomości Najnowsze nagłówki wspominające o tej firmie
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
📊
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Właściciele instytucjonalni (13F) 690 emitentów · $9.8B łącznie · Na dzień 30 czerwca 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 143 (+46 vs poprzedni kw.) | 56 (-21 vs poprzedni kw.) | 220 (+20 vs poprzedni kw.) | 190 (+12 vs poprzedni kw.) | +4.4M |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| FMR LLC | $846 470 147 | 3 512 762 | 8,60% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $731 636 247 | 3 036 213 | 7,43% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $657 763 761 | 2 729 650 | 6,68% | Akcje |
| Capital World Investors | $650 043 082 | 2 697 610 | 6,60% | Akcje |
| STATE STREET CORP | $481 895 662 | 1 999 816 | 4,89% | Akcje |
| FULLER & THALER ASSET MANAGEMENT, INC. | $394 839 917 | 1 638 544 | 4,01% | Akcje |
| DIMENSIONAL FUND ADVISORS LP | $390 196 222 | 1 619 274 | 3,96% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $297 928 728 | 1 236 065 | 3,03% | Akcje |
| AMERIPRISE FINANCIAL INC | $260 580 996 | 1 081 421 | 2,65% | Akcje |
| CITADEL ADVISORS LLC | $242 578 716 | 1 006 676 | 2,46% | Akcje |
| Swedbank AB | $233 208 837 | 967 792 | 2,37% | Akcje |
| MILLENNIUM MANAGEMENT LLC | $184 072 164 | 763 880 | 1,87% | Akcje |
| VICTORY CAPITAL MANAGEMENT INC | $165 478 678 | 686 719 | 1,68% | Akcje |
| NORGES BANK | $158 279 458 | 656 843 | 1,61% | Akcje |
| RENAISSANCE TECHNOLOGIES LLC | $135 442 731 | 562 073 | 1,38% | Akcje |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $129 891 746 | 539 037 | 1,32% | Akcje |
| Allianz Asset Management GmbH | $122 925 785 | 510 129 | 1,25% | Akcje |
| GMT Capital Corp | $109 279 895 | 453 500 | 1,11% | Akcje |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | $105 278 106 | 436 893 | 1,07% | Akcje |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $103 893 734 | 431 148 | 1,06% | Akcje |
| TWO SIGMA INVESTMENTS, LP | $96 439 086 | 400 212 | 0,98% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $95 008 929 | 394 277 | 0,96% | Akcje |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | $89 279 867 | 370 502 | 0,91% | Akcje |
| Sofinnova Investments, Inc. | $88 036 221 | 365 341 | 0,89% | Akcje |
| Polaris Capital Management, LLC | $79 270 937 | 328 966 | 0,81% | Akcje |
| AMERICAN CENTURY COMPANIES INC | $77 695 234 | 322 427 | 0,79% | Akcje |
| Bank of New York Mellon Corp | $76 961 481 | 319 382 | 0,78% | Akcje |
| GOLDENTREE ASSET MANAGEMENT LP | $70 838 675 | 294 435 | 0,72% | Akcje |
| Qube Research & Technologies Ltd | $70 056 003 | 290 725 | 0,71% | Akcje |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $66 815 854 | 277 279 | 0,68% | Akcje |
| Quantinno Capital Management LP | $65 906 960 | 273 506 | 0,67% | Akcje |
| Boston Trust Walden Corp | $64 110 068 | 266 050 | 0,65% | Akcje |
| BANK OF AMERICA CORP /DE/ | $60 589 497 | 251 440 | 0,62% | Akcje |
| Tri Locum Partners LP | $53 427 868 | 221 720 | 0,54% | Akcje |
| Iron Triangle Partners LP | $49 668 900 | 292 170 | 0,50% | Akcje |
| ARGENT CAPITAL MANAGEMENT LLC | $48 211 350 | 200 072 | 0,49% | Akcje |
| GOLDMAN SACHS GROUP INC | $45 527 185 | 188 933 | 0,46% | Akcje |
| PERCEPTIVE ADVISORS LLC | $40 964 900 | 170 000 | 0,42% | Akcje |
| RAYMOND JAMES FINANCIAL INC | $39 434 259 | 163 648 | 0,40% | Akcje |
| RHUMBLINE ADVISERS | $39 282 382 | 163 018 | 0,40% | Akcje |
| Holocene Advisors, LP | $38 794 001 | 160 991 | 0,39% | Akcje |
| Saturn V Capital Management LP | $38 781 230 | 160 938 | 0,39% | Akcje |
| PFM Health Sciences, LP | $38 740 265 | 160 768 | 0,39% | Akcje |
| Retirement Systems of Alabama | $38 473 993 | 159 663 | 0,39% | Akcje |
| Woodline Partners LP | $36 165 501 | 150 083 | 0,37% | Akcje |
| LOOMIS SAYLES & CO L P | $35 355 338 | 146 721 | 0,36% | Akcje |
| Pictet Asset Management Holding SA | $35 115 175 | 147 599 | 0,36% | Akcje |
| PRINCIPAL FINANCIAL GROUP INC | $34 163 762 | 141 776 | 0,35% | Akcje |
| STIFEL FINANCIAL CORP | $33 583 066 | 139 365 | 0,34% | Akcje |
| BNP PARIBAS FINANCIAL MARKETS | $33 026 625 | 137 057 | 0,34% | Akcje |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $32 383 478 | 134 388 | 0,33% | Akcje |
| California Public Employees Retirement System | $30 759 098 | 127 647 | 0,31% | Akcje |
| WEDGE CAPITAL MANAGEMENT L L P/NC | $30 249 134 | 160 006 | 0,31% | Akcje |
| Robeco Institutional Asset Management B.V. | $28 340 967 | 117 612 | 0,29% | Akcje |
| Gotham Asset Management, LLC | $26 992 014 | 112 014 | 0,27% | Akcje |
| Aristotle Capital Management, LLC | $26 915 626 | 111 697 | 0,27% | Akcje |
| Swiss National Bank | $26 771 767 | 111 100 | 0,27% | Akcje |
| STOREBRAND ASSET MANAGEMENT AS | $26 309 828 | 109 183 | 0,27% | Akcje |
| CANADA PENSION PLAN INVESTMENT BOARD | $25 928 372 | 107 600 | 0,26% | Akcje |
| PANAGORA ASSET MANAGEMENT INC | $25 286 187 | 104 935 | 0,26% | Akcje |
| BlackRock, Inc. | $23 889 284 | 99 138 | 0,24% | Akcje |
| Perpetual Ltd | $23 733 376 | 98 491 | 0,24% | Akcje |
| WELLINGTON MANAGEMENT GROUP LLP | $23 658 917 | 98 182 | 0,24% | Akcje |
| MORGAN STANLEY | $23 519 795 | 97 604 | 0,24% | Akcje |
| Man Group plc | $23 299 389 | 96 690 | 0,24% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $22 868 053 | 94 900 | 0,23% | Opcja sprzedaży |
| ENVESTNET ASSET MANAGEMENT INC | $22 061 835 | 91 554 | 0,22% | Akcje |
| Rhenman & Partners Asset Management AB | $21 070 417 | 87 440 | 0,21% | Akcje |
| Aberdeen Group plc | $20 146 538 | 83 606 | 0,20% | Akcje |
| Amundi | $19 114 464 | 79 323 | 0,19% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $18 916 145 | 78 500 | 0,19% | Opcja kupna |
| Schonfeld Strategic Advisors LLC | $18 620 232 | 77 272 | 0,19% | Akcje |
| FIRST TRUST ADVISORS LP | $18 149 860 | 75 320 | 0,18% | Akcje |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $17 765 513 | 73 725 | 0,18% | Akcje |
| LAZARD ASSET MANAGEMENT LLC | $16 768 620 | 69 588 | 0,17% | Akcje |
| Longaeva Partners L.P. | $16 576 808 | 68 792 | 0,17% | Akcje |
| Simplify Asset Management Inc. | $16 520 903 | 68 560 | 0,17% | Akcje |
| ALLIANCEBERNSTEIN L.P. | $16 497 448 | 87 265 | 0,17% | Akcje |
| Distillate Capital Partners LLC | $16 167 159 | 67 092 | 0,16% | Akcje |
| SEB Asset Management AB | $15 890 255 | 65 943 | 0,16% | Akcje |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $15 380 484 | 64 700 | 0,16% | Akcje |
| SEI INVESTMENTS CO | $14 931 224 | 61 963 | 0,15% | Akcje |
| Illinois Municipal Retirement Fund | $14 911 947 | 61 883 | 0,15% | Akcje |
| Tweedy, Browne Co LLC | $14 494 105 | 60 149 | 0,15% | Akcje |
| MARTINGALE ASSET MANAGEMENT L P | $14 335 788 | 59 492 | 0,15% | Akcje |
| DeepCurrents Investment Group LLC | $14 132 168 | 58 647 | 0,14% | Akcje |
| WORLDQUANT MILLENNIUM ADVISORS LLC | $13 348 774 | 55 396 | 0,14% | Akcje |
| VANGUARD ASSET MANAGEMENT, Ltd | $12 952 138 | 53 750 | 0,13% | Akcje |
| ExodusPoint Capital Management, LP | $12 819 845 | 53 201 | 0,13% | Akcje |
| Squarepoint Ops LLC | $12 807 074 | 53 148 | 0,13% | Akcje |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $12 034 356 | 63 657 | 0,12% | Akcje |
| ALGERT GLOBAL LLC | $11 749 697 | 48 760 | 0,12% | Akcje |
| CASTLEARK MANAGEMENT LLC | $11 306 312 | 46 920 | 0,11% | Akcje |
| CITADEL ADVISORS LLC | $11 253 299 | 46 700 | 0,11% | Opcja kupna |
| RENAISSANCE GROUP LLC | $11 221 601 | 46 568 | 0,11% | Akcje |
| Nuveen, LLC | $11 184 623 | 46 415 | 0,11% | Akcje |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | $10 859 795 | 45 067 | 0,11% | Akcje |
| Foundry Partners, LLC | $10 730 160 | 86 429 | 0,11% | Akcje |
| Legal & General Group Plc | $10 402 916 | 43 171 | 0,11% | Akcje |
| DEAN INVESTMENT ASSOCIATES, LLC | $10 273 274 | 42 633 | 0,10% | Akcje |
Insiderzy spółki 50 insiderów · 4 dyrektorzy generalni · 4 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Renee D Gala | President & CEO | 30 czerwca 2026 F | 147 361 | 0 | 0 | $0 |
| Philip L Johnson | EVP & Chief Financial Officer | 30 czerwca 2026 F | 56 431 | 0 | 0 | $0 |
| Neena M Patil | EVP & Chief Legal Officer | 30 czerwca 2026 F | 48 871 | 0 | 2 | $-560 664 |
| Robert Iannone | EVP, Global Head of R&D & CMO | 30 czerwca 2026 F | 85 107 | 0 | 0 | $0 |
| Bryan C Cressey | Dyrektor | 9 marca 2012 S | 27 631 | 0 | 0 | $0 |
| Zilkha M Nathaniel | Dyrektor | 10 marca 2011 A | — | 0 | 0 | $0 |
| Alexander E Albert | Dyrektor | 15 sierpnia 2008 A | — | 0 | 0 | $0 |
| Patel Jaimin | Dyrektor | 15 sierpnia 2007 A | — | 0 | 0 | $0 |
| Patrick Kennedy | — | 5 sierpnia 2026 A | 8 307 | 0 | 0 | $0 |
| Samantha Pearce | — | 5 sierpnia 2026 F | 47 131 | 0 | 1 | $-1 625 977 |
| Mark Douglas Smith | — | 5 sierpnia 2026 A | 11 285 | 0 | 1 | $-266 746 |
| Jennifer E. Cook | — | 5 sierpnia 2026 A | 12 442 | 0 | 0 | $0 |
| Laura Hamill | — | 5 sierpnia 2026 A | 8 538 | 0 | 0 | $0 |
| Heather Ann Mcsharry | — | 5 sierpnia 2026 A | 20 054 | 0 | 0 | $0 |
| Seamus Mulligan | — | 5 sierpnia 2026 A | 1 184 633 | 0 | 0 | $0 |
| Rick E Winningham | — | 5 sierpnia 2026 A | 11 172 | 0 | 2 | $-1 656 873 |
| Patrick G. Enright | — | 5 sierpnia 2026 A | 22 984 | 0 | 0 | $0 |
| Bruce C Cozadd | — | 5 sierpnia 2026 A | 362 287 | 0 | 20 | $-25 646 326 |
| Ted W Love | — | 5 sierpnia 2026 A | 3 132 | 0 | 0 | $0 |
| Norbert G Riedel | — | 5 sierpnia 2026 A | 8 629 | 0 | 1 | $-655 680 |
| Kenneth W O'Keefe | — | 2 grudnia 2025 F | 25 811 | 0 | 0 | $0 |
| Daniel N Swisher JR | — | 3 stycznia 2019 F | 16 512 | 0 | 0 | $0 |
| Suzanne Sawochka Hooper | — | 14 grudnia 2018 M | 41 184 | 0 | 0 | $0 |
| Matthew P. Young | — | 23 listopada 2018 S | 32 068 | 0 | 0 | $0 |
| MILLER MICHAEL PATRICK | — | 13 listopada 2018 S | 24 972 | 0 | 0 | $0 |
| Paul Treacy | — | 10 sierpnia 2018 S | 17 458 | 0 | 0 | $0 |
| Elmar Schnee | — | 9 sierpnia 2018 A | 6 094 | 0 | 0 | $0 |
| Peter Gray | — | 9 sierpnia 2018 A | 8 182 | 0 | 0 | $0 |
| Catherine A. Sohn | — | 9 sierpnia 2018 A | 7 654 | 0 | 0 | $0 |
| Paul L Berns | — | 9 sierpnia 2018 A | 6 772 | 0 | 0 | $0 |
| Karen J Wilson | — | 11 maja 2018 S | 15 757 | 0 | 0 | $0 |
| Karen L. Smith | — | 5 marca 2018 F | 28 474 | 0 | 0 | $0 |
| Iain Mcgill | — | 5 marca 2018 F | 22 048 | 0 | 0 | $0 |
| Russell J. Cox | — | 6 marca 2017 F | 52 795 | 0 | 0 | $0 |
| Jeffrey K Tobias | — | 5 marca 2015 F | 38 484 | 0 | 0 | $0 |
| Fintan Keegan | — | 8 lipca 2014 M | 31 750 | 0 | 0 | $0 |
| Kathryn E Falberg | — | 5 marca 2014 F | 133 387 | 0 | 0 | $0 |
| James C Momtazee | — | 13 sierpnia 2013 S | 17 315 | 0 | 0 | $0 |
| Carol A Gamble | — | 9 marca 2012 S | 32 213 | 0 | 0 | $0 |
| Alan Sebulsky | — | 9 marca 2012 S | 54 355 | 0 | 0 | $0 |
| Samuel D Colella | — | 11 stycznia 2012 M | 38 347 | 0 | 0 | $0 |
| Michael W Michelson | — | 11 stycznia 2012 M | 13 885 | 0 | 0 | $0 |
| Mark G. Eller | — | 13 sierpnia 2011 M | 4 151 | 0 | 0 | $0 |
| Michael A. Desjardin | — | 13 sierpnia 2011 M | 14 574 | 0 | 0 | $0 |
| Janne Lt Wissel | — | 31 maja 2011 J | 48 544 | 0 | 0 | $0 |
| Joan Colligan | — | 30 listopada 2010 J | 14 424 | 0 | 0 | $0 |
| Robert M Myers | — | 30 listopada 2010 J | 156 898 | 0 | 0 | $0 |
| James B Tananbaum | — | 25 sierpnia 2010 A | 21 366 | 0 | 0 | $0 |
| Samuel R Saks | — | 21 stycznia 2009 A | 358 868 | 0 | 0 | $0 |
| Matthew K Fust | — | 28 listopada 2008 J | 58 948 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Aktywiści i właściciele 5%+ 6 akcji
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| Jazz Pharmaceuticals Public Limited Company, Jazz Financing I Limited, Jazz Investments II Limited, Jazz Pharmaceuticals Italy S.p.A. ×4 zgłoszenia | 20 czerwca 2014 | — | Pierwotne zgłoszenie | — | SEC |
| KKR JP LLC, KKR Millennium Fund L.P., KKR Associates Millennium L.P., KKR Millennium GP LLC, KKR Fund Holdings L.P., KKR Fund Holdings GP Limited, KKR Group Holdings L.P., KKR Group Limited, KKR & Co. L.P., KKR Management LLC, KKR JP III LLC, KKR Partners III, L.P., KKR III GP LLC, Henry R. Kravis, George R. Roberts ×3 zgłoszenia | 12 marca 2013 | — | Pierwotne zgłoszenie | — | SEC |
| Longitude Capital Partners, LLC, Longitude Venture Partners, L.P., Longitude Capital Associates, L.P., Patrick G. Enright, Juliet Tammenoms Bakker ×3 zgłoszenia | 14 marca 2012 | — | Pierwotne zgłoszenie | Struktura kapitałowa | SEC |
| Longitude Capital Partners, LLC (2), Longitude Venture Partners, L.P. (2), Longitude Capital Associates, L.P. (2), Patrick G. Enright (2), Juliet Tammenoms Bakker (2) ×3 zgłoszenia | 30 września 2011 | — | Pierwotne zgłoszenie | — | SEC |
| Azur Pharma Limited | 28 września 2011 | — | Pierwotne zgłoszenie | M&A / sprzedaż | SEC |
| Jazz Pharmaceuticals, Inc., KKR Millennium Fund L.P., KKR Associates Millennium L.P., KKR Millennium GP LLC, KKR Partners III, L.P., KKR III GP LLC, KKR JP LLC, KKR JP III LLC | 28 kwietnia 2005 | — | Pierwotne zgłoszenie | M&A / sprzedaż | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Posiadanie ETF-ów Posiadane przez 72 fundusze ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| IHE · iShares Trust | 3,55% | 224 123 SH | 8 sierpnia 2026 | Dziennie |
| PJP · Invesco Exchange-Traded Fund Trust | 2,75% | 54 246 SH | 8 sierpnia 2026 | Dziennie |
| PTH · Invesco Exchange-Traded Fund Trust | 1,88% | 18 101 SH | 8 sierpnia 2026 | Dziennie |
| PILL · Direxion Shares ETF Trust | 1,47% | 931 NS | 30 kwietnia 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 1,10% | 3 412 SH | 8 sierpnia 2026 | Dziennie |
| RFG · Invesco Exchange-Traded Fund Trust | 1,01% | 14 167 SH | 8 sierpnia 2026 | Dziennie |
| IJK · iShares Trust | 0,86% | 367 117 SH | 8 sierpnia 2026 | Dziennie |
| IVOG · VANGUARD ADMIRAL FUNDS | 0,79% | 61 910 SH | 8 sierpnia 2026 | Dziennie |
| PDP · Invesco Exchange-Traded Fund Trust | 0,64% | 37 430 SH | 8 sierpnia 2026 | Dziennie |
| XJH · iShares Trust | 0,51% | 8 479 SH | 8 sierpnia 2026 | Dziennie |
| ISCV · iShares Trust | 0,50% | 13 756 SH | 8 sierpnia 2026 | Dziennie |
| LSVD · ADVISORS' INNER CIRCLE FUND | 0,50% | 14 803 NS | 30 kwietnia 2026 | N-PORT |
| AVMV · AMERICAN CENTURY ETF TRUST | 0,49% | 12 809 NS | 31 maja 2026 | N-PORT |
| QVMM · Invesco Exchange-Traded Fund Trust … | 0,48% | 8 322 SH | 8 sierpnia 2026 | Dziennie |
| IJH · iShares Trust | 0,44% | 2 164 793 SH | 8 sierpnia 2026 | Dziennie |
| SMMV · iShares Trust | 0,41% | 4 673 SH | 8 sierpnia 2026 | Dziennie |
| IVOO · VANGUARD ADMIRAL FUNDS | 0,41% | 101 353 SH | 8 sierpnia 2026 | Dziennie |
| VFVA · VANGUARD WELLINGTON FUND | 0,32% | 11 363 SH | 8 sierpnia 2026 | Dziennie |
| VBR · VANGUARD INDEX FUNDS | 0,31% | 867 777 SH | 8 sierpnia 2026 | Dziennie |
| AVLV · AMERICAN CENTURY ETF TRUST | 0,28% | 154 718 NS | 31 maja 2026 | N-PORT |
| VFMF · VANGUARD WELLINGTON FUND | 0,28% | 8 083 SH | 8 sierpnia 2026 | Dziennie |
| IYH · iShares Trust | 0,25% | 35 721 SH | 8 sierpnia 2026 | Dziennie |
| ISCB · iShares Trust | 0,25% | 2 794 SH | 8 sierpnia 2026 | Dziennie |
| DFAS · Dimensional ETF Trust | 0,25% | 169 973 NS | 30 kwietnia 2026 | N-PORT |
| MIDU · Direxion Shares ETF Trust | 0,24% | 1 006 NS | 30 kwietnia 2026 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0,24% | 19 561 SH | 8 sierpnia 2026 | Dziennie |
| NUSC · Nushares ETF Trust | 0,23% | 14 796 NS | 30 kwietnia 2026 | N-PORT |
| ESML · iShares Trust | 0,23% | 25 562 SH | 8 sierpnia 2026 | Dziennie |
| AVMC · AMERICAN CENTURY ETF TRUST | 0,20% | 3 508 NS | 31 maja 2026 | N-PORT |
| SMMD · iShares Trust | 0,20% | 29 882 SH | 8 sierpnia 2026 | Dziennie |
| VHT · VANGUARD WORLD FUND | 0,20% | 166 548 SH | 8 sierpnia 2026 | Dziennie |
| RWK · Invesco Exchange-Traded Fund Trust … | 0,20% | 10 307 SH | 8 sierpnia 2026 | Dziennie |
| VXF · VANGUARD INDEX FUNDS | 0,17% | 719 903 SH | 8 sierpnia 2026 | Dziennie |
| VB · VANGUARD INDEX FUNDS | 0,17% | 1 366 973 SH | 8 sierpnia 2026 | Dziennie |
| DFAT · Dimensional ETF Trust | 0,17% | 113 983 NS | 30 kwietnia 2026 | N-PORT |
| DFSV · Dimensional ETF Trust | 0,16% | 59 597 NS | 30 kwietnia 2026 | N-PORT |
| AVUQ · AMERICAN CENTURY ETF TRUST | 0,15% | 1 679 NS | 31 maja 2026 | N-PORT |
| IWS · iShares Trust | 0,15% | 89 654 SH | 8 sierpnia 2026 | Dziennie |
| AVIE · AMERICAN CENTURY ETF TRUST | 0,14% | 59 NS | 31 maja 2026 | N-PORT |
| WSML · iShares Trust | 0,13% | 3 473 SH | 8 sierpnia 2026 | Dziennie |
| AVSU · AMERICAN CENTURY ETF TRUST | 0,13% | 2 492 NS | 31 maja 2026 | N-PORT |
| IWR · iShares Trust | 0,11% | 243 081 SH | 8 sierpnia 2026 | Dziennie |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,10% | 3 276 SH | 8 sierpnia 2026 | Dziennie |
| XT · iShares Trust | 0,09% | 13 696 SH | 8 sierpnia 2026 | Dziennie |
| AVLC · AMERICAN CENTURY ETF TRUST | 0,08% | 4 239 NS | 31 maja 2026 | N-PORT |
| AVUS · AMERICAN CENTURY ETF TRUST | 0,08% | 42 911 NS | 31 maja 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,07% | 2 294 NS | 31 maja 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,07% | 147 813 NS | 30 kwietnia 2026 | N-PORT |
| DFUV · Dimensional ETF Trust | 0,06% | 45 962 NS | 30 kwietnia 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,05% | 7 081 NS | 30 kwietnia 2026 | N-PORT |